Legend Biotech (NASDAQ:LEGN – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.57) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.36) by ($0.21), MarketWatch Earnings reports. The company had revenue of $73.30 million for the quarter, compared to analysts’ expectations of $56.64 million. The business’s revenue […]
Matthews International Capital Management LLC grew its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 11.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,306,668 shares of the company’s stock after acquiring an additional 134,900 […]
Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) saw a large growth in short interest in July. As of July 31st, there was short interest totalling 6,810,000 shares, a growth of 15.8% from the July 15th total of 5,880,000 shares. Based on an average trading volume of 693,800 shares, the days-to-cover ratio is currently 9.8 […]
Legend Biotech Co. (NASDAQ:LEGN – Get Free Report)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $70.35, but opened at $64.15. Legend Biotech shares last traded at $67.46, with a volume of 154,730 shares changing hands. Analyst Upgrades and Downgrades LEGN has been the subject of a […]
Equities research analysts at Citigroup started coverage on shares of Legend Biotech (NASDAQ:LEGN – Get Free Report) in a report issued on Wednesday, FlyOnTheWall reports. The firm set a “buy” rating on the stock. LEGN has been the topic of several other research reports. BTIG Research lifted their price target on Legend Biotech from $85.00 […]